Tenax Therapeutics, Inc.TENXNASDAQ
Loading
Year-over-year book value per share growth
| Period | Value |
|---|---|
| Q4 2025 | 2.24% |
| Q3 2025 | -7.29% |
| Q2 2025 | -12.59% |
| Q1 2025 | -50.41% |
| Q4 2024 | 31.11% |
| Q3 2024 | 1.36% |
| Q2 2024 | -55.54% |
| Q1 2024 | -68.72% |
| Q4 2023 | -13.86% |
| Q3 2023 | -20.88% |
| Q2 2023 | -61.06% |
| Q1 2023 | 12004.58% |
| Q4 2022 | -99.58% |
| Q3 2022 | -44.20% |
| Q2 2022 | 322.35% |
| Q1 2022 | 49325.67% |
| Q4 2021 | -99.96% |
| Q3 2021 | 236.18% |
| Q2 2021 | 64000.66% |
| Q1 2021 | -65.81% |
| Q4 2020 | 4.69% |
| Q3 2020 | 83.68% |
| Q2 2020 | -33.83% |
| Q1 2020 | -99.95% |
| Q4 2019 | 92231.67% |
| Q3 2019 | -28.18% |
| Q2 2019 | -36.19% |
| Q1 2019 | -99.98% |
| Q4 2018 | 380850.29% |
| Q3 2018 | -21.24% |
| Q2 2018 | -23.75% |
| Q1 2018 | -10.69% |
| Q4 2017 | 1649.14% |
| Q3 2017 | -9.78% |
| Q2 2017 | -20.45% |
| Q1 2017 | -100.00% |
| Q4 2016 | 1174613.53% |
| Q3 2016 | -8.26% |
| Q2 2016 | -8.02% |
| Q1 2016 | -19.09% |